May 7,2024 Update
In the Department of Digestive Tract and General Surgery, the motto is "sufficient explanation for the patients and treatment by specialists with no complications," and we are focusing on surgical treatment of malignant tumors of the gastrointestinal tract and benign diseases. A characteristic of our department is to practice treatments in a wide range of areas while maintaining a high level of expertise.
For esophageal cancer, gastric cancer, and colorectal cancer, we actively introduce minimally invasive treatments such as endoscopic treatments (in conjunction with the Department of Gastroenterology and Hepatology) and laparoscopic surgery in response to the progression, and we strive to improve the quality of life of our patients. When it is not possible to treat with routine surgery, we aim for cures in combination with extended surgery, chemotherapy and radiotherapy (in cooperation with the Department of Radiation Oncology). In terms of function preservation, we actively aim to preserve digestive tract function after gastric cancer resections and preserve the anus in surgery for lower rectal cancers. For recurrent lesions of gastric cancer and colorectal cancer, we aim to reduce the lesions by using combinations that include effective chemotherapy and aim to heal by actively performing liver metastasis resections.
We also provide surgical treatment for relatively infrequent diseases such as esophageal achalasia, esophageal hiatus hernia, and inflammatory bowel diseases (ulcerative colitis, Crohn's disease), etc. There are also numerous surgeries in the general surgical areas such as inguinal hernia, acute appendicitis, benign anal diseases (hemorrhoids, anal fistulas, anal fissures, anal prolapse), etc.
Chemotherapy is central to the treatment of malignant tumors of the gastrointestinal tract that cannot be cured by endoscopic or surgical treatment. A number of genes in the tumor are examined to select the optimal treatment (such as the choice of chemotherapy), and we will drive the so-called cancer genome medicine. Genetic diagnosis, surgical treatment, and long-term follow-up of hereditary colorectal cancer (such as familial colorectal adenomas and Lynch syndrome) have been performed aggressively, and many patients from all over the country have been visiting us.
At unique specialist outpatient, we provide appropriate medical information (such as selection of treatment methods) and genetic diagnosis for hereditary colorectal cancers such as familial colorectal adenomas (colorectal polyposis) and Lynch syndrome. You must be counseled by a certified genetic counselor when you undergo a genetic diagnosis. Where possible, please bring a letter of referral.
The medical clinic is divided into three to four teams, practicing the most important team medicine in the surgical practice. The team rounds will be done every morning from 8:30am. The explanation before treatment and obtaining the consent form for treatment is usually done after hospitalization. The daily treatment is done by a surgical team, but we have all of the staff of the treatment departments participate in a conference (twice a week) and the general manager does rounds (once a week). Through these procedures, we examine the conditions of the hospitalized patients, confirm the treatment policy, and examine any changes. The staff of the medical department will work together to provide the best treatment for the patients. We are striving every day.
Outpatients Year 2017 | 14494 people |
Esophageal cancer | 1,332 people |
Stomach cancer | 3,382 people |
Small intestinal cancer | 26 people |
Colon cancer | 2,255 people |
Rectal cancer | 1,771 people |
Metastatic liver cancer | 30 people |
Ulcerative colitis | 239 people |
Crohn’s disease | 145 people |
Familial colorectal adenomatosis | 11 people |
Acute appendicitis | 123 people |
Ileus | 51 people |
Idiopathic esophageal rupture | 8 people |
Upper gastrointestinal tract perforation | 761 people |
Lower gastrointestinal tract perforation | 2,495 people |
Internal hemorrhoid | 446 people |
Anal fistula | 77 people |
Anal prolapse/rectal prolapse | 58 people |
Scrotal hernia | 438 people |
Femoral hernia | 14 people |
Abdominal incisional hernia | 842 people |
Admissions in 2017 | 1,485 people |
2017 - Surgeries | 934 people |
Esophageal cancer | 32 cases |
Gastric cancer | 107 cases |
Colon cancer | 145 cases |
Rectal cancer | 50 cases |
Acute appendicitis | 78 cases |
Inguinal hernia | 108 cases |
Other | 414 cases |
Name | Job Title | Position | Specialized Field | Credentials |
---|---|---|---|---|
石田 秀行 (Ishida Hideyuki) |
Professor | Chief of Clinical Services | General Surgery (Colorectlal surgery) Hereditary colorectal cancerCancer Chemotherapy |
Board Certified Surgeon (Jpn Surg Assoc, Jpn Soc Gastroenterolo Surg) Faculty(tentative), Subspecialty Board of Medical Oncology, JSMO |
熊谷 洋一 (Kumagai Yoichi) |
Professor | Vice-Chief of Clinical Services Manager of Residency Programs Chief of Education |
General Surgery (Gastric surgery) Endoscopic surgery |
Board Certified Surgeon (Jpn Surg Assoc, Jpn Soc Gastroenterolo Surg) Endoscopic surgical skill qualification system: qualified surgeon (Jpn Soc Enodsc Surg) |
松山 貴俊 (Takatoshi Matsuyama) |
Associate Professor | Manager of Inpatient Services | General Surgery (Colorectlal surgery) | Board Certified Surgeon (Jpn Surg Assoc, Jpn Soc Gastroenterolo Surg) Endoscopic surgical skill qualification system: qualified surgeon (Jpn Soc Enodsc Surg) Board Certified Fellow (Jpn Soc Gastroenterologocal Endosc) |
石畝 亨 (Ishiguro Toru) |
Associate Professor | Manager of Outpatient Services | General Surgery(Esophagp-Gastric Surgery) Endoscopic Surgery |
Board Certified Surgeon (Jpn Surg Assoc, Jpn Soc Gastroenterolo Surg) Endoscopic surgical skill qualification system: qualified surgeon (Jpn Soc Enodsc Surg) |
幡野 哲 (Hatano Satoshi) |
Associate Professor Lecturer | General Surgery(Colorectal Surgery) | Board Certified Surgeon(Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) Board Certified Fellow (Jpn Soc Gastroenterologocal Endosc) |
|
近 範泰 (Chika Noriyasu) |
Associate Professor Lecturer | Chief of Research | General Surgery(Colorectal Surgery) | Board Certified Surgeon(Jpn Surg Assoc Jpn Soc Gastroenterol Surg) |
伊藤 徹哉 (Itou Tetsuya) |
Instructor | Vice-Chief of Education | General Surgery(Esophagp-Gastric Surgery) Endoscopic Surgery |
Board Certified Surgeon(Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) Board Certified Fellow (Jpn Soc Gastroenterologocal Endosc) |
白石 壮宏 (Shiraishi Takehiro) |
Instructor | General Surgery(Colorectal Surgery) | Board Certified Surgeon(Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) Endoscopic surgical skill qualification system: qualified surgeon (Jpn Soc Enodsc Surg) |
|
千代延 記道 (Chiyonobu Norimichi) |
Instructor | Department of General Surgery(Heapato-Pancreato-Biliary Surgery) | Board Certified Surgeon(Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) Board Certified Fellow (Jpn Soc Gastroenterologocal Endosc) |
|
齋藤 稔史 (Saitou Toshifumi) |
Instructor | General Surgery(Esophagp-Gastric Surgery) Endoscopic Surgery |
Board Certified Surgeon(Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) Board Certified Fellow (Jpn Soc Gastroenterologocal Endosc) |
|
石川 博康 (Ishikawa Hiroyasu) |
Instructor | Department of General Surgery | Board Certified Surgeon (Jpn Surg Assoc) | |
杉野 葵 (Sugino Aoi) |
Instructor | Department of General Surgery | Board Certified Surgeon (Jpn Surg Assoc) | |
入江 直子 (Irie Naoko) |
Instructor | Department of General Surgery | ||
石井 挙大 (Ishii Takahiro) |
Senior resident | Department of General Surgery | ||
鈴木 佳那子 (Suzuki Kananko) |
Senior resident | Department of General Surgery | ||
石山 愛 (Ishiyama Ai) |
Senior resident | Department of General Surgery | ||
鈴木 興秀 (Suzuki Okihide) |
Associate Professor Lecturer ゲノム診療科兼担 |
General Surgery Hereditary cancer/Genetic disorders Cancer precision medicine |
Board Certified Surgeon (Jpn Surg Assoc,) | |
母里 淑子 (Mori Yoshiko) |
Associate Professor Lecturer ゲノム診療科兼担 |
General Surgery Hereditary colorectal cancer/Cancer precision medicine Cancer Chemotherapy |
Board Certified Surgeon(Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) | |
辻 美隆 (Tsuji Yoshitaka) |
Professor | Surgical Oncology | Board Certified Surgeon (Jpn Surg Assoc,Jpn Soc Gastroenterolo Surg) | |
石橋 敬一郎 (Ishibashi Keiichiro) |
Associate Professor | General Surgery(Colorectal Surgery) | Board Certified Surgeon(Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) Board Certified Fellow (Jpn Soc Gastroenterologocal Endosc) |
|
岩間 毅夫 (Iwama Takeo) |
Part-time surgeon | General Surgery Hereditary cancer |
Board Certified Surgeon (Jpn Surg Assoc,Jpn Soc Gastroenterolo Surg) | |
小倉 俊郎 (Ogura Toshiro) |
Part-time surgeon | Department of General Surgery(Heapato-Pancreato-Biliary Surgery) | Board Certified Surgeon (Jpn Surg Assoc,Jpn Soc Gastroenterolo Surg) | |
天野 邦彦 (Amano Kunihiko) |
Part-time surgeon | General Surgery(Colorectal Surgery) | Board Certified Surgeon (Jpn Surg Assoc,Jpn Soc Gastroenterolo Surg) | |
山本 梓 (Yamamoto Azusa) |
Part-time surgeon | Department of General Surgery | Board Certified Surgeon (Jpn Surg Assoc) | |
近谷 賢一 (Chikatani Kenichi) |
Part-time surgeon | General Surgery(Colorectal Surgery) | Board Certified Surgeon (Jpn Surg Assoc, Jpn Soc Gastroenterol Surg) | |
牟田 優 (Muta Yuu) |
Part-time surgeon | Department of General Surgery | Board Certified Surgeon (Jpn Surg Assoc) |
Department of Digestive Tract and General Surgery | ||||||
Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | |
午前 | ||||||
初診 |
(交替制) |
(交替制) |
(交替制) |
(交替制) |
(交替制) |
(交替制) |
再診 |
熊谷 洋一 (Kumagai Yoichi) |
石田 秀行 (Ishida Hideyuki) |
石橋 敬一郎 (Ishibashi Keiichiro) |
石畝 亨 (Ishiguro Toru) |
中田 博 (Nakata Hiroshi)(3週) |
|
松山 貴俊 (Matsuyama Takatoshi) |
母里 淑子 (Mori Yoshiko) |
白石 壮宏 (Shiraishi Takehiro) |
近 範泰 (Chika Noriyasu) |
|||
専門外来 |
肛門疾患外来 近 範泰 (Chika Noriyasu) (1、2週) |
|||||
肛門疾患外来 牟田 優 (Muta Yu) (3週) |
||||||
肛門疾患外来 天野 邦彦 (Amano Kunihiko) (4週) |
||||||
白石 壮宏 (Shiraishi Takehiro) (5週) |
||||||
午後 | ||||||
再診 |
松山 貴俊 (Matsuyama Takatoshi) |
伊藤 徹哉 (Ito Tetsuya) |
母里 淑子 (Mori Yoshiko) |
石畝 亨 (Ishiguro Toru) |
||
近谷 賢一 (Chikatani Kenichi) |
近 範泰 (Chika Noriyasu) |
中島 日出夫 (Nakajima Hideo) |
||||
猪熊 滋久 (Inokuma Shigehisa) (不定期) |
白石 壮宏 (Shiraishi Takehiro) 14時まで |
|||||
石畝 亨 (Ishiguro Toru) 14時から |
||||||
専門外来 |
大腸外来 (交替制) |
In the Department of Digestive Tract and General Surgery, we treat with a focus on (1) Surgical treatment for malignant tumors occurring in the gastrointestinal tract, such as esophageal, gastric, duodenal, small intestine, large intestine, anus, etc., (2) A multidisciplinary treatment, including chemotherapy and chemical radiation therapy for advanced esophageal cancer, gastric cancer, and colorectal cancer, (3) Surgical treatment for abdominal emergency diseases such as ileus, gastrointestinal perforation, colon diverticulitis, acute appendicitis, etc., (4) Surgical treatment of peritoneal disease (such as inguinal hernia, femoral hernia, closed hole hernia, etc.). We are always aiming to practice high quality medical care while working closely with the doctors at the medical institutions to which we have referred.
The number of annual surgeries for gastrointestinal malignancies in recent years consists of 25 to 30 cases of esophageal cancer. 100 to 120 gastric cancers and 180 to 200 colorectal cancers, and the proportion of arthroscopic surgery is increasing every year. Even with advanced and re-carcinogenesis, there is a significant increase in opportunities for resection due to advances in chemotherapy, and we are actively resecting with a focus on the liver metastasis of gastric and colorectal cancer, not only to improve the survival rate, but also to practice a multidisciplinary treatment aimed at healing and not just improving the survival rate. In order to actively participate in regional cooperation, we are committed to the surgery and dissemination of local cooperation paths for gastric cancer and colorectal cancer, so we may ask you to have a mutual physician's relationship with the patients who you have referred to us for five years after the surgery.
The number of patients with hereditary carcinoma of the colon and rectum (digestive tract polyposis and Lynch syndrome) is extremely large and they are referred from all over the country. Minimally invasive treatment and genetic diagnosis of colorectal polyposis and duodenal polyposis is possible.
We have built a system to respond promptly and accurately, not just to elective
surgery but also to acute abdominal diseases which are mainly abdominal emergency
diseases.
Although the treatment policy is standardized for each disease under the
responsibility of the general manager of the medical care policy, the individual
support is done in detail based on the risk assessment and we strive to reduce the
complications. Our staff is prepared with all of our body and soul to provide the
best medical care.
Please contact the following for the inquiries or consultation from patients.
Contact information | Gastrointestinal tract and general surgical instructor Toru Ishiguro(itoru@saitama-med.ac.jp) |
Person in charge of second opinions | |
Colorectal diseases (including hereditary tumors) and others | Director and professor, Hideyuki Ishida |
Gastric diseases | Dupty director professor, Erito Mochigi |
Esophageal diseases | Assoc. Prof., Youichi Kumagai |